Cardiovascular health status of population in Beijing

ObjectiveCardiovascular Health Index (CHI) (2017) was used to analyze the current cardiovascular health status in Beijing, to provide guidance for cardiovascular disease prevention and control, and provide basis for formulating policies.

MethodsBased on the provincial research results of CHI (2017), score of CHI and each dimension of Beijing were analyzed. The full score was 100, and the higher the value, the better.

ResultsThe score of CHI (2017) in Beijing was 75.4 which ranked first in China. The CHI score of cardiovascular disease prevalence (A dimension) was 68.0, lower than that in Shanghai (76.6), and ranked 9^th in China. The prevalence of cardiovascular disease scored 22.3. The CHI score of exposure of risk factors (B dimension) was 37.0, lower than that in Shanghai (49.6), and ranked 27^th in China. The metabolic index scored 8.5. The prevalence of overweight, obesity, central obesity, hypertension, diabetes mellitus and hyperlipidemia was 33.1%, 25.9%, 47.8%, 35.5%, 19.4% and 36.7%, respectively, higher than that of Shanghai and the whole country. The CHI score of prevention and control of risk factors (C dimension) was 96.0 which ranked the first in China. The awareness, treatment and control rate of hypertension was 49.2%, 42.0% and 14.9%, respectively. The CHI score of treatment of cardiovascular disease (D dimension) was 62.0 which ranked first in China. The treatment capacity ranked first in China. The number of emergency vehicles, chest pain centers and stroke centers was 85.6 per million, 0.2 per million and 0.5 per million, respectively. The score of treatment process and outcome was 41.1 and 64.1, respectively. The score of public policy and service capacity (E dimension) was 77.1, lower than that in Shanghai (79.5), and ranked second in China. Among total 52 indicators of CHI (2017), 26 indicators in Beijing were worse than that in Shanghai

ConclusionBeijing ranked first in the prevention and control of cardiovascular disease risk factors, also ranked first in the treatment capacity of cardiovascular disease in China. However, the prevalence of cardiovascular disease and related risk factors, especially metabolic indicators, was high. The control rate of hypertension needs to be improved. The number of chest pain centers and stroke centers was not adequate. The treatment process and outcome of cardiovascular need to be improved. The development of chronic disease insurance policy was lagging behind.